Showing results (11-20 of 2,328) with videos related to
Sort By:
Pageof 233
Gynecologic Oncology|January 11, 2011
Overview of anti-angiogenic agents in development for ovarian cancerRobert A BurgerSeminars in Cancer Biology|October 2, 2010
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targetingJan A BurgerMethods in Molecular Biology (Clifton, N.J.)|April 3, 2013
The use of the MegaBACE for sequencing and genotype analysisPamela A BurgerCancer Journal (Sudbury, Mass.)|November 26, 2019
Bruton Tyrosine Kinase Inhibitors: Present and FutureJan A BurgerAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A BurgerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A BurgerExpert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A BurgerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A BurgerPageof 233